FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888671741> ?p ?o ?g. }

• W2888671741 endingPage "54" @default.
• W2888671741 startingPage "44" @default.
• W2888671741 abstract "Non-coding RNAs play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). The aim of this study was to characterize the therapeutic role of melatonin as well as the underlying molecular mechanism (its effects on the expression of H19 and its downstream signaling pathways) in the treatment of PAH. Real-time PCR and western blot analysis were performed to evaluate the expression of H19, miR-200a, miR-675, insulin-like growth factor-1 receptor (IGF1R), and programmed cell death 4 (PDCD4). The value of systolic pulmonary artery pressure (SPAP) and the ratio of medial thickening in the monocrotaline (MCT) group were increased, whereas the melatonin treatment could decrease these values to some extent. The weights of RV (right ventricle), LV (left ventricle) + IVS (interventricular septal), and RV/(LV + IVS) in the MCT group were much higher than those in the MCT + melatonin and control groups. In addition, the expression of H19, miR-675, IGF1R mRNA, and IGF1R protein in the MCT group was the highest, whereas their expression in the control group was the lowest. The expression of miR-200, PDCD4 mRNA, and PDCD4 protein in the MCT group was the lowest, whereas their expression in the control group was the highest. Furthermore, H19 directly suppressed the expression of miR-200a, whereas miR-675-3p and miR-200a directly inhibited the expression of IGF1R and PDCD4, respectively. Finally, melatonin treatment inhibited cell proliferation; upregulated the expression of H19, miR-675-3p, and PDCD4; and downregulated the expression of miR-200a and IGF1R. This study demonstrated the role of H19-miR-675-3p-IGF1R- and H19-miR-200a-PDCD4-signaling pathways in the melatonin treatment of PAH. Non-coding RNAs play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). The aim of this study was to characterize the therapeutic role of melatonin as well as the underlying molecular mechanism (its effects on the expression of H19 and its downstream signaling pathways) in the treatment of PAH. Real-time PCR and western blot analysis were performed to evaluate the expression of H19, miR-200a, miR-675, insulin-like growth factor-1 receptor (IGF1R), and programmed cell death 4 (PDCD4). The value of systolic pulmonary artery pressure (SPAP) and the ratio of medial thickening in the monocrotaline (MCT) group were increased, whereas the melatonin treatment could decrease these values to some extent. The weights of RV (right ventricle), LV (left ventricle) + IVS (interventricular septal), and RV/(LV + IVS) in the MCT group were much higher than those in the MCT + melatonin and control groups. In addition, the expression of H19, miR-675, IGF1R mRNA, and IGF1R protein in the MCT group was the highest, whereas their expression in the control group was the lowest. The expression of miR-200, PDCD4 mRNA, and PDCD4 protein in the MCT group was the lowest, whereas their expression in the control group was the highest. Furthermore, H19 directly suppressed the expression of miR-200a, whereas miR-675-3p and miR-200a directly inhibited the expression of IGF1R and PDCD4, respectively. Finally, melatonin treatment inhibited cell proliferation; upregulated the expression of H19, miR-675-3p, and PDCD4; and downregulated the expression of miR-200a and IGF1R. This study demonstrated the role of H19-miR-675-3p-IGF1R- and H19-miR-200a-PDCD4-signaling pathways in the melatonin treatment of PAH." @default.
• W2888671741 created "2018-08-31" @default.
• W2888671741 creator A5005945631 @default.
• W2888671741 creator A5009554161 @default.
• W2888671741 creator A5011900841 @default.
• W2888671741 creator A5022876276 @default.
• W2888671741 creator A5031957846 @default.
• W2888671741 creator A5033733653 @default.
• W2888671741 creator A5063162390 @default.
• W2888671741 creator A5063691131 @default.
• W2888671741 creator A5074329137 @default.
• W2888671741 creator A5080922192 @default.
• W2888671741 creator A5086048082 @default.
• W2888671741 date "2018-12-01" @default.
• W2888671741 modified "2023-10-11" @default.
• W2888671741 title "Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin" @default.
• W2888671741 cites W1545627154 @default.
• W2888671741 cites W183341991 @default.
• W2888671741 cites W1973921593 @default.
• W2888671741 cites W1984546307 @default.
• W2888671741 cites W1987686589 @default.
• W2888671741 cites W1995291683 @default.
• W2888671741 cites W2020021066 @default.
• W2888671741 cites W2022199909 @default.
• W2888671741 cites W2023857791 @default.
• W2888671741 cites W2032183472 @default.
• W2888671741 cites W2032559539 @default.
• W2888671741 cites W2032619610 @default.
• W2888671741 cites W2037527967 @default.
• W2888671741 cites W204164459 @default.
• W2888671741 cites W2042245784 @default.
• W2888671741 cites W2045158856 @default.
• W2888671741 cites W2052525451 @default.
• W2888671741 cites W2055929468 @default.
• W2888671741 cites W2058659458 @default.
• W2888671741 cites W2058923462 @default.
• W2888671741 cites W2059881173 @default.
• W2888671741 cites W2062190072 @default.
• W2888671741 cites W2066445704 @default.
• W2888671741 cites W2078614391 @default.
• W2888671741 cites W2079983771 @default.
• W2888671741 cites W2087377443 @default.
• W2888671741 cites W2089456852 @default.
• W2888671741 cites W2091161969 @default.
• W2888671741 cites W2094584580 @default.
• W2888671741 cites W2094637120 @default.
• W2888671741 cites W2096166765 @default.
• W2888671741 cites W2098180530 @default.
• W2888671741 cites W2105952005 @default.
• W2888671741 cites W2108805152 @default.
• W2888671741 cites W2111013440 @default.
• W2888671741 cites W2111047063 @default.
• W2888671741 cites W2111479290 @default.
• W2888671741 cites W2113554645 @default.
• W2888671741 cites W2121948013 @default.
• W2888671741 cites W2128619556 @default.
• W2888671741 cites W2137354848 @default.
• W2888671741 cites W2139960175 @default.
• W2888671741 cites W2145526021 @default.
• W2888671741 cites W2147787157 @default.
• W2888671741 cites W2149499233 @default.
• W2888671741 cites W2153638986 @default.
• W2888671741 cites W2156718903 @default.
• W2888671741 cites W2165946847 @default.
• W2888671741 cites W2169220357 @default.
• W2888671741 cites W2171797570 @default.
• W2888671741 cites W2335004067 @default.
• W2888671741 cites W2401717789 @default.
• W2888671741 cites W2436871840 @default.
• W2888671741 cites W2586968928 @default.
• W2888671741 cites W2618790607 @default.
• W2888671741 cites W2748929947 @default.
• W2888671741 cites W2749020520 @default.
• W2888671741 cites W2877011020 @default.
• W2888671741 cites W4251765607 @default.
• W2888671741 cites W960848489 @default.
• W2888671741 doi "https://doi.org/10.1016/j.omtn.2018.08.015" @default.
• W2888671741 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6146608" @default.
• W2888671741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240970" @default.
• W2888671741 hasPublicationYear "2018" @default.
• W2888671741 type Work @default.
• W2888671741 sameAs 2888671741 @default.
• W2888671741 citedByCount "42" @default.
• W2888671741 countsByYear W28886717412019 @default.
• W2888671741 countsByYear W28886717412020 @default.
• W2888671741 countsByYear W28886717412021 @default.
• W2888671741 countsByYear W28886717412022 @default.
• W2888671741 countsByYear W28886717412023 @default.
• W2888671741 crossrefType "journal-article" @default.
• W2888671741 hasAuthorship W2888671741A5005945631 @default.
• W2888671741 hasAuthorship W2888671741A5009554161 @default.
• W2888671741 hasAuthorship W2888671741A5011900841 @default.
• W2888671741 hasAuthorship W2888671741A5022876276 @default.
• W2888671741 hasAuthorship W2888671741A5031957846 @default.
• W2888671741 hasAuthorship W2888671741A5033733653 @default.
• W2888671741 hasAuthorship W2888671741A5063162390 @default.
• W2888671741 hasAuthorship W2888671741A5063691131 @default.
• W2888671741 hasAuthorship W2888671741A5074329137 @default.

• next